MAXINE PASCAL: Open Payments
NPI 1356064380 · CARMEL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 66 payments from 19 companies in 2025. Trend: 2023 $1,714 · 2024 $1,880 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $375 |
| LEO Pharma Inc. | 2 | $87 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| Incyte Corporation | 3 | $53 |
| UCB, Inc. | 3 | $51 |
| Janssen Biotech, Inc. | 3 | $49 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Amgen Inc. | 2 | $36 |
Products named: SKYRIZI, DUPIXENT, ANZUPGO, OPZELURA, Bimzelx, TREMFYA, COSENTYX, NEMLUVIO.
Industry payments across NY — which companies pay providers there.
